FDA Inspection 1113679 — Kalocsai, Krisztina
The FDA completed an inspection of Kalocsai, Krisztina on December 5, 2019 in Budapest Ix. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 5, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Budapest Ix (Hungary)
Additional Details
Clinical Investigator (CI)